PHARMA
Quarterly rpt on consolidated results for the financial period ended 30/6/2003
PHARMANIAGA BERHAD |
Quarterly report for the financial period ended | 30/06/2003 |
Quarter | 2 |
Financial Year End | 31/12/2003 |
The figures | have not been audited |
SUMMARY OF KEY FINANCIAL INFORMATION30/06/2003 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
30/06/2003 | 30/06/2002 | 30/06/2003 | 30/06/2002 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
1 | Revenue | 155,262 | 157,420 | 309,787 | 298,096 |
2 | Profit/(loss) before tax | 13,347 | 16,866 | 31,260 | 30,358 |
3 | Profit/(loss) after tax and minority interest | 8,389 | 11,147 | 20,035 | 18,489 |
4 | Net profit/(loss) for the period | 8,389 | 11,147 | 20,035 | 18,489 |
5 | Basic earnings/(loss) per share (sen) | 8.40 | 11.10 | 20.00 | 18.50 |
6 | Dividend per share (sen) | 0.00 | 0.00 | 0.00 | 0.00 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
7 | Net tangible assets per share (RM) | 1.9500 | 1.8000 |
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
Remarks : |
The Board of Directors of Pharmaniaga Berhad recommends an interim tax exempt dividend of 3.5 sen per share for the current financial period ended 30 June 2003. (2002: tax exempt dividend of 2.5 sen per share) The date of the book closure will be announced in due course. |
Announcement Info
Company Name | PHARMANIAGA BERHAD |
Stock Name | PHARMA |
Date Announced | 19 Aug 2003 |
Category | Financial Results |
Reference No | CR-030819-51193 |